SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0001104659-20-073794
Filing Date
2020-06-16
Accepted
2020-06-16 16:33:12
Documents
12
Period of Report
2020-06-12
Items
Item 5.02: Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers: Compensatory Arrangements of Certain Officers
Item 5.07: Submission of Matters to a Vote of Security Holders
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 FORM 8-K tm2022678d_8k.htm   iXBRL 8-K 48101
  Complete submission text file 0001104659-20-073794.txt   222781

Data Files

Seq Description Document Type Size
2 XBRL TAXONOMY EXTENSION SCHEMA regn-20200612.xsd EX-101.SCH 3189
3 XBRL TAXONOMY EXTENSION LABEL LINKBASE regn-20200612_lab.xml EX-101.LAB 34591
4 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE regn-20200612_pre.xml EX-101.PRE 22712
7 EXTRACTED XBRL INSTANCE DOCUMENT tm2022678d_8k_htm.xml XML 3523
Mailing Address 777 OLD SAW MILL RIVER ROAD TARRYTOWN NY 10591
Business Address 777 OLD SAW MILL RIVER ROAD TARRYTOWN NY 10591 9148477000
REGENERON PHARMACEUTICALS, INC. (Filer) CIK: 0000872589 (see all company filings)

IRS No.: 133444607 | State of Incorp.: NY | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 000-19034 | Film No.: 20966825
SIC: 2834 Pharmaceutical Preparations
Office of Life Sciences